NPPB and chronic thromboembolic pulmonary hypertension: Therefore, studies tried to use both 6MWD and NT‐proBNP for risk stratification for iPAH, CTD‐PAH and chronic thromboembolic pulmonary hypertension (CTEPH).20, 21 It turns out that the patients at high risk of poor prognosis were identified with the two simple markers.